Walleye Capital’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-403,739
| Closed | -$1.18M | – | 2263 |
|
|
2024
Q4 | $1.18M | Buy |
403,739
+295,365
| +273% | +$862K | ﹤0.01% | 881 |
|
|
2024
Q3 | $419K | Buy |
+108,374
| New | +$419K | ﹤0.01% | 1417 |
|
|
2024
Q2 | – | Sell |
-10,443
| Closed | -$73.1K | – | 2899 |
|
|
2024
Q1 | $73.1K | Sell |
10,443
-57,863
| -85% | -$405K | ﹤0.01% | 2070 |
|
|
2023
Q4 | $605K | Buy |
68,306
+57,606
| +538% | +$510K | ﹤0.01% | 1100 |
|
|
2023
Q3 | $102K | Buy |
+10,700
| New | +$102K | ﹤0.01% | 1658 |
|
|
2023
Q1 | – | Sell |
-30,000
| Closed | -$557K | – | 2587 |
|
|
2022
Q4 | $557K | Buy |
+30,000
| New | +$557K | 0.01% | 950 |
|